Management of primary cutaneous lymphoma patients during COVID‐19 pandemic: EORTC CLTF guidelines Maarten Vermeer

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

During severe inflammatory coronavirus infectious disease (CoVID‐19) pandemic and based on evidence on COVID‐19 epidemiology, patients with primary cutaneous lymphomas (PCLs) have risk for developing complicated COVID‐19 infections in consideration of their older age (majority above 60) and their potential underlying predisposing conditions (e.g. hypertension, diabetes). ^1,2,3 Moreover, PCL patients with aggressive biologic behavior should be carefully monitored according to guidelines for patients with neoplastic disease.

Related collections

Author and article information

Contributors

Evangelia Papadavid: papadavev@yahoo.gr

Journal

Journal ID (nlm-ta): J Eur Acad Dermatol Venereol

Journal ID (iso-abbrev): J Eur Acad Dermatol Venereol

Journal ID (doi): 10.1111/(ISSN)1468-3083

Journal ID (publisher-id): JDV

Title: Journal of the European Academy of Dermatology and Venereology

Publisher: John Wiley and Sons Inc. (Hoboken )

ISSN (Print): 0926-9959

ISSN (Electronic): 1468-3083

Publication date (Electronic): 16 May 2020

Electronic Location Identifier: 10.1111/jdv.16593

Affiliations

[ ¹ ] National and Kapodistrian University of Athens 2ndDermatology Department Athens Greece

[ ² ] University Hospital Birmingham UK

[ ³ ] University 12 of Octubre Dermatology Department Madrid Spain

[ ⁴ ] University of Turin Department of Dermatology Turin Italy

[ ⁵ ] University of Leiden Netherlands

[ ⁶ ] Medical University of Vienna Department of Dermatology Vienna Austria

[ ⁷ ] Johannes Wesling Klinikum Minden Department of Dermatology, Venerology, Allergology und Phlebology Minden Germany

[ ⁸ ] CHU Paris Hospital St Louis Lariboisiete Paris France

Author notes

[*] [* ] Corresponding author

Prof Evangelia Papadavid, Chair 2 ^nd Dermatology Department, National and Kapodistrian University of Athens, Greece, Attikon University Hospital

Email: papadavev@ 123456yahoo.gr

Article

Publisher ID: JDV16593

DOI: 10.1111/jdv.16593

PMC ID: 7276772

PubMed ID: 32416629

SO-VID: fc2bea41-9f10-4d1f-ae77-d435156ff756

License:

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

History

Page count

Figures: 0, Tables: 0, Pages: 11, Words: 205

Custom metadata

source-schema-version-number 2.0

edited-state accepted-manuscript

details-of-publishers-convertor Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.4 mode:remove_FC converted:08.06.2020

ScienceOpen disciplines: Dermatology

Keywords: cpvod‐19,primary cutaneous lymphomas,eortc cltf guidelines

Data availability:

ScienceOpen disciplines: Dermatology

Keywords: cpvod‐19, primary cutaneous lymphomas, eortc cltf guidelines

Comments

Comment on this article

scite_

Cited by 7

See all cited by

- Version 1